GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimeric Therapeutics Ltd (ASX:CHM) » Definitions » Tax Rate %

Chimeric Therapeutics (ASX:CHM) Tax Rate % : -5.07% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Chimeric Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Chimeric Therapeutics's Tax Expense for the six months ended in Dec. 2024 was A$0.14 Mil. Chimeric Therapeutics's Pre-Tax Income for the six months ended in Dec. 2024 was A$-2.72 Mil. Therefore, Chimeric Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 was -5.07%.


Chimeric Therapeutics Tax Rate % Historical Data

The historical data trend for Chimeric Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimeric Therapeutics Tax Rate % Chart

Chimeric Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Tax Rate %
- -1.13 -0.37 -0.08

Chimeric Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Rate % Get a 7-Day Free Trial -0.89 0.09 -3.08 -0.56 -5.07

Chimeric Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Chimeric Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2024 )/Pre-Tax Income (A: Jun. 2024 )
=0.01/-12.52
=-0.08 %

Chimeric Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Dec. 2024 )/Pre-Tax Income (Q: Dec. 2024 )
=0.138/-2.72
=-5.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chimeric Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Chimeric Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chimeric Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.

Chimeric Therapeutics Headlines

No Headlines